Ranibizumab

7 registered clinical trials studyying Ranibizumab.

Status	Trial	Sponsor	Phase
Unknown	A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabeti NCT05248334	Tianjin Medical University Eye Hospital	Phase 1
Completed	Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retino NCT06173245	Egyptian Biomedical Research Network	N/A
Completed	Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity NCT05701124	Zagazig University	Phase 3
Unknown	Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion NCT04062370	Sun Yat-sen University	Phase 4
Unknown	Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR) NCT03452657	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Phase 3
Completed	Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRV NCT03054766	Beijing Hospital	N/A
Unknown	Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study NCT02914626	LEANDRO CABRAL ZACHARIAS	Phase 3